Utilizing its proprietary DNA technology to write synthetic libraries, Twist Biopharma provides end-to-end antibody and TCR discovery libraries including both (1) highly diverse synthetic naïve scFv and VHH antibody phage display libraries to discover targeting domains for CAR-T constructs, and (2) combinatorically assembled TCR libraries from gene fragments. In this talk, Aaron Sato, CSO, will present several POC data on how these technologies can be utilized for cell therapies.
In this webinar you will learn…
- Twist Bioscience provides protein engineering tools for researchers to rapidly advance through the design and test phases of their CAR research pipeline.
- Identify high quality ligand binding domain hits in as little as 12 weeks with Twist Biopharma Expertise.
- Twist Bioscience offers cloned genes, oligo pools and TCR screening libraries for the rapid identification of functional alpha and beta chains for effective antigen targeting.